Lustra
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
ultraviolet-induced skin discolorations
General Information
Lustra has been approved for the treatment of
ultraviolet-induced skin discolorations and hyperpigmentation
associated with pregnancy, superficial trauma and the use of oral
contraceptives and hormone replacement therapy.
Clinical Results
In clinical studies, Lustra demonstrated substantial reduction
in pigmented lesions in a two-week period, and the reservoir effect
of Lustra reduced damage from ultraviolet radiation versus
placebo.
Mechanism of Action
Lustra contains 4% hydroquinone in a vehicle containing glycolic
acid and an antioxidant complex.
